incretin hormone glp 1 Incretin-based therapy of metabolic disease Incretins role in metabolic homeostasis
Description
Slow dose escalation improves tolerance and minimizes the potential risks
doi:10.1093/abbs/gms107 60
Oxyntomodulin ELISA AL-139
Research: The STEP trials assessed weight loss in people with obesity receiving a once-weekly injection of semaglutide (Wegovy) over 17 months (68 weeks)
